Lisata Therapeutics, Inc.
LSTA • NASDAQ • Stock Fundamentals
Lisata Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David J. Mazzo, with a market cap of $29.1M.
Market Cap$29.1M
Employees25.0
CEODavid J. Mazzo
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Lisata Therapeutics, Inc. FAQ
Common questions about Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. (LSTA) has a market capitalization of $29.1M and trades on NASDAQ.
Lisata Therapeutics, Inc. has approximately 25 employees.